Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansion

Area of Science:

• Molecular biology
• Hematology
• Cancer research

Background:

• Chromosomal translocations, particularly t(8;21), are common in acute myeloid leukemia (AML).
• The RUNX1/ETO fusion protein, resulting from t(8;21), plays a critical role in leukemogenesis.
• The RUNX1/ETO protein contains nervy homology regions (NHRs) crucial for its function.

Purpose of the Study:

• To investigate the specific roles and essentiality of the NHR2 and NHR4 domains within the RUNX1/ETO fusion protein.
• To determine if the functions of NHR2 and NHR4 can be substituted by heterologous protein domains.

Main Methods:

• Construction and analysis of C-terminally truncated RUNX1/ETO variants with altered NHR domains.
• Assessment of nuclear translocation, DNA binding, target gene repression, and progenitor cell transformation.
• Utilizing an inducible protein assembly system to study early functional requirements.

Main Results:

• A truncated RUNX1/ETO lacking NHR3/4 and with a substituted NHR2 domain retained nuclear localization and DNA binding but lost oncogenic activity.
• Restoration of transforming capacity was achieved by fusing NHR4 or a N-CoR repressor domain to the truncated protein.
• NHR4 domain activity was critical early in the process for cells expressing the modified RUNX1/ETO.

Conclusions:

• The NHR2 and NHR4 domains of RUNX1/ETO are not structurally indispensable and can be functionally replaced by heterologous domains.
• RUNX1/ETO activity can be reconstituted through modular recombination of functional domains, including those from RUNX1, ETO, BCR, and N-CoR.
• The findings suggest that the recurrent translocation of RUNX1 to ETO family members may be due to the presence of essential tetramerization and transcriptional repression moieties in ETO.